title: [Irinotecan and fluorouracil in combination in colorectal carcinoma: a little clarity].
authors.affiliation: Unità Operativa di Oncologia Medica, Ospedali Riuniti, Bergamo.
authors.forename: P
authors.initials: P
authors.lastname: Poletti
authors.forename: G D
authors.initials: GD
authors.lastname: Beretta
authors.forename: S
authors.initials: S
authors.lastname: Mosconi
authors.forename: M A
authors.initials: MA
authors.lastname: Pessi
authors.forename: R
authors.initials: R
authors.lastname: Labianca
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002166:Camptothecin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007261:Infusions, Intra-Arterial; D000077146:Irinotecan; D016032:Randomized Controlled Trials as Topic
chemical_list: D000077146:Irinotecan; D005472:Fluorouracil; D002166:Camptothecin
vernacular_title: Irinotecan e fluorouracile in associazione nel carcinoma del colon-retto: un po' di chiarezza.